or Try an Advanced Search...

    Tyrosine Kinase Receptors Stocks List

    Symbol Grade Name % Change
    DCPH A Deciphera Pharmaceuticals, Inc. 0.08
    FUSN A Fusion Pharmaceuticals Inc. 0.00
    MACK B Merrimack Pharmaceuticals, Inc. 0.13
    ELVN B Enliven Therapeutics, Inc. -2.53
    TYRA C Tyra Biosciences, Inc. 0.43
    BPMC C Blueprint Medicines Corporation -2.40
    BDTX C Black Diamond Therapeutics, Inc. -3.37
    BBIO C BridgeBio Pharma, Inc. 1.58
    PBYI D Puma Biotechnology Inc -3.80
    PRLD D Prelude Therapeutics Incorporated 1.58
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Clinical Development Fibroblast Growth Factor Receptor Cell Biology Epidermal Growth Factor Receptor Her2 Tyrosine Kinase Antibodies Biology Biotechnology Bladder Cancer Blastoma Breast Cancer Cancer Treatment Fibroblast Growth Factor Gastrointestinal Gastrointestinal Stromal Tumor Genetic Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase Receptors stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 8.92
    BBP C BioShares Biotechnology Products Fund 7.26
    MRGR C ProShares Merger ETF 5.05
    WDNA C WisdomTree BioRevolution Fund 4.46
    BTEC C Principal Healthcare Innovators Index ETF 3.6
    View all Tyrosine Kinase Receptors ETFs...
    Compare ETFs
    Compare BBP to MRGR Compare CNCR to BTEC Compare CNCR to MRGR

        Tyrosine Kinase Receptors Stocks Recent News

        Date Stock Title
        May 14 ELVN Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
        May 14 BPMC Blueprint Medicines started at buy by Stephens, citing Ayvakit franchise
        May 14 BBIO BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024
        May 13 TYRA Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
        May 13 BBIO BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantly Reduced All-Cause Mortality in a Pre-specified Sen...
        May 12 BBIO Cantor picks 14 undervalued biotech stocks worth a second look
        May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
        May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
        May 10 DCPH Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
        May 10 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
        May 10 BDTX Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?
        May 10 TYRA Tyra Biosciences GAAP EPS of -$0.35 beats by $0.11
        May 10 FUSN Fusion Pharmaceuticals doses first subject in prostate cancer trial
        May 9 FUSN Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer
        May 9 TYRA Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
        May 9 MACK Merrimack Pharmaceuticals intends to declare $15.10 dividend
        May 9 BDTX Black Diamond Therapeutics GAAP EPS of -$0.35 beats by $0.08
        May 9 MACK Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
        May 9 BDTX Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 9 PRLD Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Clinical Development Fibroblast Growth Factor Receptor Cell Biology Epidermal Growth Factor Receptor Her2 Tyrosine Kinase Antibodies Biology Biotechnology Bladder Cancer Blastoma Breast Cancer Cancer Treatment Fibroblast Growth Factor Gastrointestinal Gastrointestinal Stromal Tumor Genetic Diseases
        Tyrosine Kinase Receptors

        Tyrosine kinase receptors are a type of cell surface receptor that binds to specific molecules and activates a signal transduction pathway inside the cell. They are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. They are also involved in the regulation of the immune system and in the development of cancer.

        Browse All Tags